Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
In-House Recombinant Hepatitis B Vaccine at Birth in Indonesian Infants
NCT07854847Phase 3Not yet recruiting
- Sponsor
- Bio Farma
- Start
- Oct 2026
- Primary completion
- Feb 2027
01
Overview
A Phase 3 trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by Bio Farma. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT07854847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07854847.